Nanomedicine captures cardiovascular disease

Arterioscler Thromb Vasc Biol. 2008 May;28(5):801-2. doi: 10.1161/ATVBAHA.108.165332.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Angioplasty, Balloon / adverse effects
  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Atherosclerosis / drug therapy
  • Atherosclerosis / pathology
  • Atherosclerosis / prevention & control
  • Cardiovascular Diseases / diagnosis*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / pathology
  • Constriction, Pathologic / drug therapy
  • Constriction, Pathologic / pathology
  • Constriction, Pathologic / prevention & control
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / pathology
  • Femoral Artery / drug effects
  • Femoral Artery / pathology
  • Humans
  • Nanomedicine / methods*
  • Nanoparticles / administration & dosage
  • Nanoparticles / therapeutic use
  • Rabbits
  • Sirolimus / administration & dosage
  • Sirolimus / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Sirolimus